Preliminary results from a phase II trial of tipifarnib in squamous cell carcinomas (SCCs) with HRAS mutations

A. L. Ho, N. Chau, J. Bauman, K. Bible, A. Chintakuntlawar, M. E. Cabanillas, D. J. Wong, I. Braña Garcia, M. S. Brose, V. Boni, C. Even, M. Razaq, V. Mishra, K. Bracken, D. Wages, C. Scholz, A. Gualberto

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)viii373
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
StatePublished - Oct 1 2018

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this